Literature DB >> 3210544

Causes, kinetics and clinical implications of post-hemodialysis urea rebound.

L A Pedrini1, S Zereik, S Rasmy.   

Abstract

The rapid increase in end-dialysis urea concentration (Co) immediately after the end of dialysis (HD), which greatly exceeds that expected as an effect of urea generation and defined as "net rebound," was assessed in 21 chronic HD patients. The curve of serial values of net rebound correlated (r = 0.70) with the theoretical curve predicted by the two pool urea kinetics model (UKM). A mean equilibrium concentration (Ce) was achieved in 48 minutes, with a 7.58% increase in Co. Stabilized rebound (Re) was compared after four different HD procedures, and significant correlations were found between the magnitude of Re and the indexes of HD efficiency, dialyzer clearance (r = 0.75) and Kt/V (r = 0.68). The highest values of Re (8.6% and 8.8%) were observed after the procedures with largest urea removal, irrespective of the biocompatibility conditions (new or reused dialyzers). The single pool UKM applied with the stabilized end-HD urea concentration Ce instead of Co resulted in more physiological values of urea distribution volume (56.1% vs. 50.5% of body wt) and in lower values of Kt/V (0.64 vs. 0.73, P less than 0.001) and protein catabolic rate (1.07 vs. 1.17 g/kg/day, P less than 0.001). A reequilibration process, rather than protein hypercatabolism, seems to be responsible for most rebound, the magnitude of which correlated with the efficiency of the procedure. Only by considering Ce as the true end-HD urea concentration it is possible to minimize the errors arising from the application of a single pool analysis to a two pool system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3210544     DOI: 10.1038/ki.1988.255

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Linear spectral deconvolution of catabolic plasma concentration decay in dialysis.

Authors:  D Liberati; F Turkheimer
Journal:  Med Biol Eng Comput       Date:  1999-05       Impact factor: 2.602

Review 2.  Hemodialysis in children: general practical guidelines.

Authors:  M Fischbach; A Edefonti; C Schröder; A Watson
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

Review 3.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

4.  Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project.

Authors:  Stuart L Goldstein; Andrew Brem; Bradley A Warady; Barbara Fivush; Diane Frankenfield
Journal:  Pediatr Nephrol       Date:  2006-05-17       Impact factor: 3.714

5.  Reliability of haemodialysis urea kinetic modelling in children.

Authors:  T Buur; M G Bradbury; S W Smye; J T Brocklebank
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

6.  Mathematical modelling of haemodialysis in children.

Authors:  J H Evans; S W Smye; J T Brocklebank
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

7.  The effect of hemodialysis on protein metabolism. A leucine kinetic study.

Authors:  V S Lim; D M Bier; M J Flanigan; S T Sum-Ping
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  New compartmental model approach to dialysis.

Authors:  D Liberati; S Biasioli; R Foroni; F Rudello; F Turkheimer
Journal:  Med Biol Eng Comput       Date:  1993-03       Impact factor: 2.602

9.  Assessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric database.

Authors:  Waleed M Sweileh; Sa'ed H Zyoud; Samah W Al-Jabi; Ansam F Sawalha
Journal:  BMC Res Notes       Date:  2014-04-23

10.  Monitoring dialysis adequacy: history and current practice.

Authors:  Linda Ding; James Johnston; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2021-01-05       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.